6I1O image
Entry Detail
PDB ID:
6I1O
Keywords:
Title:
Fab fragment of an antibody selective for wild-type alpha-1-antitrypsin
Biological Source:
Source Organism:
PDB Version:
Deposition Date:
2018-10-29
Release Date:
2019-11-20
Method Details:
Experimental Method:
Resolution:
1.93 Å
R-Value Free:
0.23
R-Value Work:
0.19
R-Value Observed:
0.20
Space Group:
P 32 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:FAB 2H2 heavy chain
Chain IDs:A (auth: H)
Chain Length:216
Number of Molecules:1
Biological Source:Mus musculus
Polymer Type:polypeptide(L)
Description:FAB 2H2 light chain
Chain IDs:B (auth: L)
Chain Length:213
Number of Molecules:1
Biological Source:Mus musculus
Primary Citation
Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsin.
JCI Insight 5 ? ? (2020)
PMID: 32699193 DOI: 10.1172/jci.insight.135459

Abstact

The α-1-antitrypsin (or alpha-1-antitrypsin, A1AT) Z variant is the primary cause of severe A1AT deficiency and forms polymeric chains that aggregate in the endoplasmic reticulum of hepatocytes. Around 2%-5% of Europeans are heterozygous for the Z and WT M allele, and there is evidence of increased risk of liver disease when compared with MM A1AT individuals. We have shown that Z and M A1AT can copolymerize in cell models, but there has been no direct observation of heteropolymer formation in vivo. To this end, we developed a monoclonal antibody (mAb2H2) that specifically binds to M in preference to Z A1AT, localized its epitope using crystallography to a region perturbed by the Z (Glu342Lys) substitution, and used Fab fragments to label polymers isolated from an MZ heterozygote liver explant. Glu342 is critical to the affinity of mAb2H2, since it also recognized the mild S-deficiency variant (Glu264Val) present in circulating polymers from SZ heterozygotes. Negative-stain electron microscopy of the Fab2H2-labeled liver polymers revealed that M comprises around 6% of the polymer subunits in the MZ liver sample. These data demonstrate that Z A1AT can form heteropolymers with polymerization-inert variants in vivo with implications for liver disease in heterozygous individuals.

Legend

Protein

Chemical

Disease

Primary Citation of related structures